Cargando…
OTME-10. Integrated analysis of human gliomas at the single cell level identifies S100A4 as a novel immunotherapy target
Understanding the immune composition of a given tumor is critical to assess its potential responsiveness to cancer immunotherapy. This is especially true for tumors that are intrinsically resistant to immunotherapies, such as GBM. Unfortunately, studies on the functional heterogeneity and associated...
Autores principales: | Abdelfattah, Nourhan, Kumar, Parveen, Leu, Jia-Shiun, Flynn, William, Baskin, David, Ptichumani, Kumar, Ijare, Omkar, George, Joshy, Yun, Kyuson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255435/ http://dx.doi.org/10.1093/noajnl/vdab070.061 |
Ejemplares similares
-
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
por: Abdelfattah, Nourhan, et al.
Publicado: (2022) -
FSMP-02. CHANGES IN GLUTAMINE METABOLISM INDUCED BY OXALOACETATE IN GLIOBLASTOMA
por: Ijare, Omkar, et al.
Publicado: (2021) -
OTME-23. Single-cell transcriptomic and epigenomic immune landscape of isocitrate dehydrogenase stratified human gliomas
por: Gupta, Pravesh, et al.
Publicado: (2021) -
OTME-14. TGF-beta signaling in microtube formation of glioblastoma
por: Storevik, Simon, et al.
Publicado: (2021) -
OTME-4. IDH mutated gliomas promote epileptogenesis via D-2-hydroxyglutarate dependent mTOR hyperactivation
por: Mortazavi, Armin, et al.
Publicado: (2021)